SCI, SSCI ve AHCI tarafından taranan dergilerde yayımlanmış veya kabul edilmiş makaleler

Uluslararası

• E.Y.Tükel , O.Ateş and Y.Kiraz.
  (2024) In Silico Drug Repurposing Against PSMB8 as a Potential Target for Acute Myeloid Leukemia Treatment.
  Molecular Biotechnology ,

• B.Budak , E.Y.Tükel , B.Turanlı and Y. Kiraz.
  (2024) Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities.
  Annals Of Hematology ,

• A.Adan , G.Alizada , Y.Kiraz , A.Nalbant and Y.Baran.
  (2017) Flow cytometry: Basic Principles and Applications.
  Critical Reviews In Biotechnology , Vol. 37, No. 2, 163-176,

• Y.Kiraz , Y.Baran , A.Nalbant.
  (2016) T cells in tumor microenvironment.
  Tumor Biology , Vol. 37, No. 1, 39-45,

• Y.Kiraz , V.Neergeen-Bhujun , N.Rummun , Y.Baran.
  (2016) Apoptotic effects of non-edible parts of Punica granatum on human multiple myeloma cells.
  Tumor Biology , Vol. 37, No. 2, 1803-1815,

• P.Mutlu , Y.Kiraz , U.Gündüz , Y.Baran.
  (2015) An Update on Molecular Biology and Drug Resistance Mechanisms of Multiple Myeloma.
  Critical Reviews In Biotechnology , Vol. 96, No. 3, 413-424,

• M.Unlu , Y.Kiraz , F.N.Kacı , Y.Baran.
  (2014) Multidrug Resistance in Chronic Myeloid Leukemia.
  Turkish Journal Of Biology , Vol. 38, No. 6, 806-816,

Diğer indexler tarafından taranan dergilerde yayımlanmış veya kabul edilmiş makaleler

Uluslararası

• Y.Kiraz , Y.Akdoğan , İ.Maşalacı , Ö.Mutlu and H.Eyvaz.
  (2023) In Silico Approach for Identification of PI3K/mTOR Dual Inhibitors for Multiple Myeloma Treatment.
  European Journal Of Biology ,

• C.Ergun , B.Z.Kiremitci , G.Arslantaş , B.Bozkurt , G.Ayna Duran and Y.Kiraz.
  (2023) Exploring PI3K Pathway Inhibitors for Acute Myeloid Leukemia: A Drug-Repurposing Approach.
  Experimed , Vol. 13, No. 3, 205-212,

• M.Kartal Yandım , A.Adan , Y.Kiraz , Y.Baran.
  (2015) Regenerative Medicine.
  J Med Oncol-Special Topics , Vol. 8, No. 2, 10-14,